Código QR (código de barras bidimensional)

Therapeutic Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors represent a novel class of medications for managing dyslipidemia. Although previous meta-analyses have confirmed their efficacy in lowering low-density lipoprotein cholesterol (LDL-C), few have evaluated their effects on br...

Fuld beskrivelse

Na minha lista:
Principais autores: Nur Hafidha Hikmayani, Ratih Puspita Febrinasari, Ariq Ratya Satwika
Format: Artigo
Sprog:Inglês
Udgivet: Universitas Padjadjaran 2025-09-01
Serier:Althea Medical Journal
Fag:
alirocumab
cholesterol
dyslipidemia
evolocumab
pcsk9 inhibitors
Online adgang:https://journal.fk.unpad.ac.id/index.php/amj/article/view/4209
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker